Deletion of two prostate cancer risk-associated CTCF anchor regions by CRISP-Cas9 resulted in highly elevated expression of genes within the loops, suggesting that disruption of TAD organization could alter gene expression and contribute to prostate tumorigenesis (81). The gene discussed is CTCF; the disease is prostate carcinoma.